Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA) – Annals of Surgical Oncology

Access options Buy single article Instant access to the full article PDF. US$ 39.95 Tax calculation will be finalised during checkout. Fig. 1 …

Read the full article here

Related Articles